- Home
- RPRX vs RF Comparison
RPRX vs RF Comparison
Compare RPRX & RF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | RPRX | RF |
|---|---|---|
| Founded | 1996 | 1970 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Major Banks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 19.5B | 24.1B |
| IPO Year | 2020 | N/A |
Fundamental Metrics
Financial Performance| Metric | RPRX | RF |
|---|---|---|
| Price | $49.42 | $28.28 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 4 | 15 |
| Target Price | ★ $50.00 | $29.13 |
| AVG Volume (30 Days) | 2.6M | ★ 12.4M |
| Earning Date | 05-06-2026 | 04-17-2026 |
| Dividend Yield | 1.88% | ★ 3.77% |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 1.78 | N/A |
| Revenue | ★ $2,378,193,000.00 | N/A |
| Revenue This Year | $38.30 | $14.98 |
| Revenue Next Year | $4.80 | $3.82 |
| P/E Ratio | $28.08 | ★ $13.07 |
| Revenue Growth | ★ 5.06 | N/A |
| 52 Week Low | $31.58 | $19.31 |
| 52 Week High | $49.99 | $31.53 |
Technical Indicators
Market Signals| Indicator | RPRX | RF |
|---|---|---|
| Relative Strength Index (RSI) | 63.60 | 64.08 |
| Support Level | $35.32 | $26.53 |
| Resistance Level | N/A | $29.12 |
| Average True Range (ATR) | 0.93 | 0.64 |
| MACD | 0.11 | 0.24 |
| Stochastic Oscillator | 81.92 | 88.19 |
Price Performance
Historical ComparisonAbout RPRX Royalty Pharma plc
Royalty Pharma PLC is the largest buyer of biopharmaceutical royalties. The firm has a portfolio of royalties that entitles it to payments based on the sales of biopharma products. Royalty Pharma receives royalties on more than 35 commercial products, including AbbVie and Johnson & Johnson's Imbruvica (for chronic lymphocytic leukemia and other blood cancers), Biogen's Tysabri (for relapsing forms of multiple sclerosis), Vertex's cystic fibrosis franchise, and 10 development-stage product candidates.
About RF Regions Financial Corporation
Regions Financial is one of the midsized regional banks in the US, with around $160 billion in total assets as of Sept. 30, 2025. Headquartered in Birmingham, Alabama, Regions Financial has a footprint mostly in the US southeast. The bank provides a diversified set of financial services in retail banking, commercial banking, card and treasury management, wealth management, and capital markets.